Ethypharm
Records under this name other than the patents Ethypharm holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 18 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,603,525 | Multilayer orally disintegrating tablet Lapsed on the fee record Ended Dec 10, 2025 · From the USPTO record | Lapsed on the fee record | Ended Dec 10, 2025 | From the USPTO record |
| US 7,829,122 | Microgranules based on active principle and method for making same Term ended Term ended Apr 26, 2025 · From the USPTO record | Term ended | Term ended Apr 26, 2025 | From the USPTO record |
| US 7,691,408 | Composition Having Gelling Properties for the Prolonged Delivery of Bioactive Substances Term ended Term ended Apr 25, 2025 · High confidence | Term ended | Term ended Apr 25, 2025 | High confidence |
| US 7,718,194 | Coated particles with prolonged release and tablets containing same Term ended Term ended Mar 18, 2025 · From the USPTO record | Term ended | Term ended Mar 18, 2025 | From the USPTO record |
| US 9,446,002 | Spheroids and multiparticulate tablets comprising them Term ended Term ended Apr 4, 2024 · From the USPTO record | Term ended | Term ended Apr 4, 2024 | From the USPTO record |
| US 7,863,331 | Pharmaceutical composition containing fenofibrate and method for the preparation thereof Term ended Term ended Dec 18, 2023 · From the USPTO record | Term ended | Term ended Dec 18, 2023 | From the USPTO record |
| US 8,029,825 | Low-dose tablets having a network of polymers Lapsed on the fee record Ended Oct 4, 2023 · From the USPTO record | Lapsed on the fee record | Ended Oct 4, 2023 | From the USPTO record |
| US 8,658,212 | Pharmaceutical composition containing fenofibrate and method for the preparation thereof Term ended Term ended Nov 9, 2022 · From the USPTO record | Term ended | Term ended Nov 9, 2022 | From the USPTO record |
| US 7,781,174 | Proliferation Markers in Clinical Practice and Their Use for Cancer Prognosis or Diagnosis Formerly held Lapsed on the fee record Ended Aug 24, 2022 · High confidence | Lapsed on the fee record | Ended Aug 24, 2022 | High confidence |
| US 6,967,028 | Prolonged release microspheres for injectable administration Formerly held Term ended Term ended May 31, 2022 · From the USPTO record | Term ended | Term ended May 31, 2022 | From the USPTO record |